Over the past few months, the Global-PPS team has been busy updating the real-time feedback report. They now also provide insight into prevalence’s for the different antibiotic subgroups, healthcare-associated infections and use of invasive devices and the novel WHO AWaRE classification.
On 5 April 2021, the Global-PPS team published a paper in the Journal of Antimicrobial Chemotherapy that focuses on hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe).
Dr. Irma Korinteli, a pediatrician and lecturer at Tbilisi State Medical University, has been involved in the Global-PPS project from the very beginning in 2015. Earlier this year, she successfully defended her PhD on antibiotic use in Georgian hospitals. Read her testimonial below!
The Global-PPS protocol is adapted to survey COVID-19 patients. The website is translated in French, Japanese, Russian and Spanish. More languages will follow. Read two nice stories on how the Global-PPS is rolled out at national level and how these data can be used for a PhD.
The Global-PPS in Iran primarily started in 2015 in two large Iranian University cities, namely Shiraz and Kurdistan Universities of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium.
As countries worldwide are faced with an unprecedented pandemic, there is a profound concern that widespread antibiotic use in COVID-19 patients could increase the selective pressure for antibiotic resistance.
The Global-PPS was successfully conducted in 2015 and included 335 institutions from 53 countries of 6 continents worldwide.